Cytokinetics | CYTK - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Acadia Pharmaceuticals USD 171.09M 1.9M 2026-03
Amgen USD 541M 1000K 2026-06
Arca Biopharma USD 50.17M 1.45M 2026-03
Bayer EUR 982.42M 0 2026-06
Biogen USD 146.7M 200K 2025-09
Brainstorm Cell Therapeutics USD 11.04M 0 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Capricor Therapeutics USD 57.37M 11.65M 2025-12
Cytokinetics USD 124.43M 2.17M 2026-03
Eisai JPY 282.46M 345K 2026-06
Eli Lilly USD 943.5M 3.33M 2026-03
Exelixis USD 248.88M 4.82M 2026-06
Geron USD 640.9M 2.54M 2026-03
Halozyme Therapeutics USD 114.04M 4.48M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Merck USD 2.47B 4.93M 2026-03
Novartis USD 1.9B 7.38M 2026-06
Pfizer USD 5.7B 0 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.21B 8.25M 2026-03